1. 1) Gilead Sciences, Inc., “Working to Supply Remdesivir for COVID-19.”:〈https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-remdesivir-for-covid-19〉, cited 7 July, 2020.
2. 2) Matsuyama S., Kawase M., Nao N., Shirato K., Ujike M., Kamitani W., Shimojima M., Fukushi S., bioRxiv, 2020.2003.2011.987016 (2020).
3. 3) Jeon S., Ko M., Lee J., Choi I., Byun S. Y., Park S., Shum D., Kim S., Antimicrob. Agents Chemother., 64, e00819-20 (2020).
4. 4) Lavorini F., ISRN Allergy, 102418 (2013).
5. 5) Hardwell A., Barber V., Hargadon T., McKnight E., Holmes J., Levy M. L., Prim. Care Respir. J., 20, 92-96 (2011).